PERSPECTA

News from every angle

← Back to headlines

Argenx Leads European Biotech Surge with Trial Success

European biotech firm Argenx has seen its stock soar following successful trial results, contributing to a strong week for biotech stocks across the Atlantic.

21 Aug, 06:27 — 21 Aug, 06:27
PostShare

Sources

Showing 1 of 1 sources
bloombergHigh3d ago

Europe Has Its Own Biotech Star as Argenx Soars on Trial Success

It’s been a big week for biotech stocks on both sides of the Atlantic.

By Lisa Pham

Read full article →

Related Stories

Tuya Reports Second Quarter 2026 Unaudited Financial Results

30m ago

Indian-Origin Ex-CEO Pays $1.8 Million to Resolve False Claims Case

37m ago

Donald Trump Invests in Elon Musk's SpaceX

37m ago

(LEAD) Hyundai Motor, labor union tentatively reach wage deal

53m ago